Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review-Reference-Cited by-同舟云学术

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review

Published:2023-08-05 Issue:5 Volume:12 Page:1533-1551
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Blumenfeld Andrew M.^ORCID,Lipton Richard B.,Silberstein Stephen,Tepper Stewart J.,Charleston Larry^ORCID,Landy Stephen^ORCID,Kuruvilla Deena E.^ORCID,Manack Adams Aubrey

Funder

AbbVie

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s40120-023-00529-x.pdf

Reference130 articles.

1. Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1–211.

2. Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2020;60:2340–56.

3. Weiss A, Nowak-Sliwinska P. Current trends in multidrug optimization: an alley of future successful treatment of complex disorders. SLAS Technol. 2017;22:254–75.

4. Ailani J, Burch RC, Robbins MS. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61:1021–39.

5. American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59:1–18.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group;Headache: The Journal of Head and Face Pain;2024-08-16

2. Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety;Frontiers in Pharmacology;2023-12-13